Analysts give their take on Medicare reform
The prospect of a prescription drug benefit for the elderly in the US has led to share price hikes in Euro pharma companies; SG Cowen analyses the impact.
Archives for November 19, 2003
Agilent back in the black at year-end
Agilent returns to profit for the first time in two years in the fourth quarter ended October 31, as cost-cutting compensated for a modest decline in revenues.
For mass protein production, try moss
Dow Chemical has teamed up with Germany's greenovation Biotech to develop ways of manufacturing therapeutic proteins such as monoclonal antibodies in plants.
Intercell farms out oligonucleotide production
Transgenomic has won a contract to manufacture an oligonucleotide-based ingredient for an adjuvant candidate used to increase the immunogenicity of vaccines.
Celltech closes proteomics unit
UK biotechnology bellwether Celltech has announced plans to close its proteomics unit in early 2004 at a cost of £5.5million (€7.8m), giving up on the search to find a buyer for the business.
Crucell adds development head
Dutch biotechnology company Crucell has put in place another element in its strategy to develop in-house drug products functions with the appointment of a new vice president of development.
Effervescent route to improved solubility
CIMA is granted a US patent covering the use of effervescence to improve the absorption of poorly-soluble drugs and target delivery to specific areas of the GI tract.